Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0770
+0.0066 (9.37%)
Dec 22, 2025, 4:00 PM EST
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $8.03 million as of December 23, 2025. Its market cap has increased by 2.88% in one year.
Market Cap
8.03M
Enterprise Value
9.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.08
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 8.03M, a decrease of -68.53%. That is a compound annual growth rate of -14.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 8.03M | 2.94% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | 23.39M | -4.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |